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Abstract
In this review, we place redox signaling in pancreatic β-cells to the context with 
signaling pathways leading to insulin secretion, acting for example upon the action 
of incretins (GLP-1, GIP) and the metabotropic receptor GPR40. Besides a brief 
description of ion channel participation in depolarization/repolarization of the 
plasma membrane, we emphasize a prominent role of the elevated glucose level in 
pancreatic β-cells during glucose-stimulated insulin secretion (GSIS). We focus on 
our recent findings, which revealed that for GSIS, not only elevated ATP synthesis is 
required, but also fundamental redox signaling originating from the NADPH oxidase 
4- (NOX4-) mediated H2O2 production. We hypothesized that the closing of the ATP-
sensitive K+ channel (KATP) is only possible when both ATP plus H2O2 are elevated in 
INS-1E cells. KATP alone or with synergic channels provides an element of logical sum, 
integrating both metabolic plus redox homeostasis. This is also valid for other secreta-
gogues, such as branched chain ketoacids (BCKAs); and partly for fatty acids (FAs). 
Branched chain aminoacids, leucine, valine and isoleucine, after being converted to 
BCKAs are metabolized by a series of reactions resembling β-oxidation of FAs. This 
increases superoxide formation in mitochondria, including its portion elevated due to 
the function of electron transfer flavoprotein ubiquinone oxidoreductase (ETF:QOR). 
After superoxide conversion to H2O2 the oxidation of BCKAs provides the mitochon-
drial redox signaling extending up to the plasma membrane to induce its depolariza-
tion together with the elevated ATP. In contrast, experimental FA-stimulated insulin 
secretion in the presence of non-stimulating glucose concentrations is predominantly 
mediated by GPR40, for which intramitochondrial redox signaling activates phos-
pholipase iPLA2γ, cleaving free FAs from mitochondrial membranes, which diffuse 
to the plasma membrane and largely amplify the GPR40 response. These events are 
concomitant to the insulin release due to the metabolic component. Hypothetically, 
redox signaling may proceed by simple H2O2 diffusion or via an SH-relay enabled by 
peroxiredoxins to target proteins. However, these aspects have yet to be elucidated.
Keywords: pancreatic β-cells, insulin secretion, redox signaling, NADPH oxidase 4, 
branched chain ketoacid oxidation, fatty acid β-oxidation, ATP-sensitive K+ channel, 
GLP1, GPR40
1. Introduction
Recently, we revealed that physiological redox signaling is essential for the first 
phase of glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells. Elevated 
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glucose intake contributes to the increasing pentose phosphate pathway (PPP) 
supply of NADPH for NADPH oxidase 4 (NOX4), which directly produces H2O2. 
The burst of H2O2 then represents a redox signal, which fundamentally determines 
GSIS, while inducing a cooperative induction of plasma membrane depolarization 
together with ATP elevation (Figure 1) [1]. The latter originates from the increased 
ATP synthesis by oxidative phosphorylation (OXPHOS). Hypothetically, either 
a closure of the ATP-sensitive K+ channel (KATP) is dependent on both H2O2 plus 
ATP; or H2O2 activates a synergic channel such as transient receptor potential 
Figure 1. 
(A) Traditional (“standard”) view of the triggering mechanism of GSIS compared with (B) new paradigm 
in GSIS mechanism (“novel”), for which the redox signaling by NOX4-produced H2O2 is essentially required. 
Upon the glucose intake, PPP and redox shuttles supply cytosolic NADPH to increase NOX4 activity and 
thus elevate H2O2 which substantiates redox signaling. Either, the ATP-sensitive K
+ channel (KATP) is closed 
exclusively when both ATP plus H2O2 are elevated. Alternatively, H2O2 activates opening of TRPM2 or other 
nonspecific cation channels required for a depolarization shift to reach a threshold potential of −50 mV, 
at which the voltage-sensitive Ca2+ channels (CaL) become open, thus starting to fire the action potential. 
Resulting Ca2+ influx into the cell cytosol allows a complex process of exocytosis of the insulin granule vesicles 
(IGVs), beginning during the so-called 1st phase of GSIS by fusion of pre-attached IGVs with the plasma 
membrane and exposure of the IGV interior to the extracellular space (capillaries in vivo). Ca2+ also promotes 
the recruitment of distant IGVs towards the plasma membrane as well as ensures the late, so-called 2nd phase 
of GSIS, lasting about 1 hour in vivo.
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melastin 2 (TRPM2) [2], required for sufficient depolarization. This principle of 
a logical summation of metabolic plus redox stimulation seems to be universal for 
other secretagogues (i.e. compounds stimulating insulin secretion), dependent 
on KATP. However, note that the redox signaling must be distinguished from the 
 oxidative stress [3–6].
2. Two phases of GSIS
Two phases exist for GSIS in vivo [7–11]. They are also recognized in isolated 
pancreatic islets (PIs), but not in insulin-secreting β-cell lines. The consensus 
became that both KATP-dependent mechanism (also termed „triggering”) and 
KATP-independent mechanisms contribute to both phases [12], while the KATP-
independent mechanism still requires the elevation of cytosolic Ca2+ [13]. The 2nd 
phase in vivo was even considered to be independent of the extracellular glucose 
concentrations [14]. It depends more on the molecular mechanism of the increased 
sustained mobilization and priming of insulin granule vesicles (IGVs) [15].
The first rapid peak of insulin secretion is observed at 5–10 min after adminis-
tration of a bolus of glucose in vivo or addition of glucose to the isolated PIs. The 1st 
phase involves the exocytosis of pre-docked juxtaposed IGVs, residing 100–200 nm 
from the plasma membrane prior to triggering [16, 17] and also possesses a 
contribution of deeper localized granules arriving within 50 ms, which were not 
initially pre-docked [18, 19]. The 2nd phase typically lasts over 1 hr. As a result, a 
predominant insulin amount is released in this phase. The 2nd phase results most 
likely from further delayed recruitment of IGVs belonging to the typically excessive 
reserve. The past hypothesis suggested a main reason for such a delay to involve the 
restricted passage through the filamentous actin (F-actin) cytoskeleton [20–22], 
but later a microfilament-independent movement of IGVs was reported [21, 23–25]. 
However, numerous cytoskeleton components play a more detailed role in the IGV 
exocytosis, not representing only a simple barrier. Generally, the IGV exocytosis 
relies on synaptogamin activation by Ca2+, syntaxin, SNAP-25, and other target 
proteins of the SNARE family (SNAp REceptors, where SNAP is soluble NSF attach-
ment proteins and NSF is a N-ethylmaleimide-sensitive fusion factor). They attract 
IGVs via the IGV-localized synaptobrevins (vesicle-associated membrane proteins), 
while forming a coiled-coil quarternaly structure [26]. The resulting SNARE core 
complex relocates the IGV and plasma membrane into proximity, thus facilitating 
establishment of so-called fusion stalk. Further zippering of coiled-coil structures 
allows fusion of larger part of the IGV membrane with the plasma membrane until 
a fusion pore is formed.
However, the recent explanation for the second phase is based on the fact that 
the two phases of insulin secretion exist when isolated pancreatic islets are studied, 
but do not exist for isolated primary pancreatic β-cells [27–29]. Hence, the role of 
inter-cellular contacts is emphasized for the 2nd phase. The inter-cellular contacts 
allow synchronization of the plasma membrane potential, while paracrine hormone 
secretion may also contribute to modification and termination of insulin release.
3. Mechanisms of the 1st phase of GSIS
GSIS has been consensually described to involve a so-called triggering mecha-
nism accompanied by amplifying mechanism(s) [7, 12, 30–36]. The triggering 
is exclusively dependent on the KATP closure and attaining plasma membrane 
depolarization up to −50 mV. The latter is achieved in a synergy of KATP with other 
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ion channels. The amplifying mechanisms are given by metabolism or stem from 
the action of incretins and other hormones. Also, mechanisms concerning other 
secretagogues, such as branched chain ketoacids (BCKAs) and fatty acids (FAs), 
were considered as merely amplifying. Nevertheless, we will show below the 
ambiguity of such a classification. The amplifying mechanisms originate from an 
incremental increase in Ca2+ elevations, not existing within the canonical “trigger-
ing” mechanism. Alternatively, they stem from facilitation via numerous proteins 
of the exocytotic machinery localized either on the IGV or plasma membranes. 
Therefore, some of these types of events might be Ca2+ independent and hence may 
also proceed at low glucose concentrations.
The traditional explanation of the triggering mechanism of GSIS relied 
 exclusively on the ATP elevation (or elevation of the ATP/ADP ratio) in the cytosol 
of β-cells. Sole elevated ATP was considered to be sufficient for the KATP closing 
[30–33]. Any additional requirement for a parallel redox signaling was not consid-
ered, despite the findings that reactive oxygen species (ROS) have been implicated 
in insulin secretion. This concerned with at least ROS of mitochondrial origin [37], 
or resulting from mono-oleoyl-glycerol addition [38]. The blockage of PPP, that 
decreased insulin secretion, also shifted redox homeostasis [39]. An unspecified link 
of GSIS with the externally added H2O2 was reported, besides antioxidant effects 
at decreased glutathione by diethylmaleate [40]. Previously, also an unidentified 
isoform of NADPH oxidase was implicated in GSIS, since an antisense p47PHOX 
oligonucleotide [41] or an unspecific NOX inhibitors  attenuated GSIS [38, 42, 43].
Recently, we have provided the evidence that the elevated OXPHOS is insuf-
ficient to initiate GSIS, despite the increased ATP levels and the elevated ATP/
ADP ratio at the peri-plasma- membrane space [1]. We demonstrated that NOX4 is 
fundamentally required for GSIS [1]. In model rat pancreatic β-cells (INS-1E cells) 
with silenced NOX4 or in full NOX4 knockout (NOX4KO) mice and in mice with 
NOX4 knockout, specifically in pancreatic β-cells (NOX4βKO mice), the 1st phase 
of GSIS was largely blocked [1]. In both studied NOX4 KO mice strains and in their 
isolated PIs, the 1st phase of GSIS was abolished with NOX4 ablation, while in PIs, 
either overexpression of NOX4 (achieved at least in the peripheral spheroid layer of 
islets) or additions of H2O2 rescued this 1st phase. No effects were found in NOX2 
KO mice, although NOX2 has been previously implicated to play an antagonistic 
role for redox homeostasis [44].
Moreover, using a patch-clamp of INS-1E cells, we demonstrated that the KATP 
closure is possible only when NOX4 is intact in INS-1E cells. After showing the well-
known closure of KATP induced by high glucose concentration in cells transfected 
with scrambled siRNA, we observed no glucose-induced KATP closure in INS-1E 
cells silenced for NOX4 [1]. These experiments supported the model, in which 
KATP integrates metabolic and redox homeostasis and acts as a logical summation 
for which both elevated ATP plus elevated H2O2 exclusively lead to a triggering of 
GSIS (Figure 1). However, since without cation fluxes provided by nonspecific 
cation channels a threshold depolarization of −50 mV cannot be achieved, despite 
100% KATP ensemble being closed [45, 46], we may also hypothesize that H2O2 
 alternatively or in parallel activates the TRPM2 channel [2], known to contain 
redox-sensitive Met residue [47].
Thus our results set a new paradigm for GSIS, since it had never been considered 
that the sole ATP increase is insufficient for GSIS and is insufficient particularly for 
the closing of KATP; as well as it had never been considered that any redox signaling 
might essentially participate in GSIS.
In further work, we also demonstrated that the redox signaling upon GSIS is 
provided by elevations of cytosolic H2O2, whereas ROS in the mitochondrial matrix 
(both H2O2 and superoxide release) are diminished due to the enhanced operation 
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of the redox shuttles upon GSIS [48]. One may expect that a portion of cytosolic 
NADPH as a substrate for NOX4 is provided by the glucose-6-phosphate dehydro-
genase and also by 6-phosphogluconate dehydrogenase downstream within the PPP, 
whereas the second portion is generated due to the operation of redox shuttles. These 
shuttles become more active at higher glucose concentrations and increasingly pro-
duce NADPH. NADPH is particularly produced by isocitrate dehydrogenase 1 (IDH1) 
and malic enzyme 1 (ME1) in the cytosol upon operation of these redox shuttles [48].
In summary, we describe the revisited mechanism of the 1st phase of GSIS as 
follows. Elevated glucose metabolism and glycolysis allows an increased branching 
of the metabolic flux, particularly of glucose-6-phosphate G6P, toward PPP, which 
acts as a predominant source of NADPH. The essential role of PPP was emphasized 
elsewhere [49]. Amplification of the cytosolic NADPH is also provided by IDH1 
and ME1 due to the elevated operation of the three redox shuttles. Since NOX4 
was determined as the only NADPH oxidase producing H2O2 directly [50, 51], 
its reaction results in an increase of H2O2 release into the cell cytosol [1]. Finally, 
the elevated H2O2, together with concomitantly elevated ATP from the enhanced 
OXPHOS, is the only way for plasma membrane depolarization up to −50 mV [1]. 
This threshold subsequently induces CaL opening, followed by the Ca
2+ influx into 
the cell cytosol, which in turn induces the exocytosis of insulin granule vesicles. The 
action potential spikes are then determined by the cycles of CaL opening, followed 
by the opening of voltage-dependent channels (KV) in rodents [52] or calcium-
dependent (KCa) K
+-channels in humans. Their action deactivates CaL, which are, 
however, again activated in the next CaL-KV cycle.
Pancreatic β-cells were undoubtedly adapted by phylogenesis to serve as a 
 perfect glucose sensor. The glucose sensing is allowed by several key specific 
features. At first, specific isoforms of glucose transporters, GLUT2 in rodents 
and GLUT1 in humans, equilibrate the plasma glucose concentration with the 
glucose concentration in the cytosol of β-cells [53, 54]. Second, a specific isoform 
IV of hexokinase (also termed glucokinase) cannot be feed-back inhibited by its 
product glucose-6-phosphate. As a result, there is an efficient unidirectional flux 
towards the glycolysis [55, 56] and, most probably, this allows also branching into 
the PPP [49]. Originally, the PPP was accounted to utilize only 10% of glucose, due 
to presumably feed-back inhibition by glucose [57, 58]. However, metabolomics 
studies associated PPP intermediates with GSIS [59], confirming previous studies 
with various PPP inhibitors [59–62]. These results collectively demonstrated the 
important PPP contribution to GSIS. This contribution is also reflected by existing 
patients having a deficiency of glucose-6-phosphate dehydrogenase associated with 
the impaired 1st phase of GSIS [63].
The third aspect leading to the perfect glucose sensing lays in the virtual absence 
of lactate dehydrogenase in β-cells and inefficiency in pyruvate dehydrogenase 
kinases (PDK) [64]. PDKs would otherwise block pyruvate dehydrogenase (PDH). 
Thus the highly active PDH and other dehydrogenases, activated also by Ca2+ influx 
into the mitochondrial matrix [65], altogether enable that 100% of pyruvate and its 
equivalents (after pyruvate conversion by transaminases) is utilized by OXPHOS. 
A minor pyruvate flux ensures anaplerosis of oxaloacetate due to the reaction of 
pyruvate carboxylase [66]. Its reaction is also important also for the pyruvate/
malate redox shuttle.
The fourth aspect reflects the in vivo inhibitory role of the mitochondrial 
ATPase inhibitory factor, IF1. IF1 adjusts a proper glucose concentration range for 
GSIS in rat pancreatic β-cells, INS-1E [67, 68]. This is suggested by the demonstra-
tion that IF1 silencing allows insulin secretion even at very low glucose approaching 
to zero in INS-1E cells [67]. In contrast, the IF1 overexpression inhibited GSIS in 
INS-1E cells [68]. This IF1 role awaits confirmation in vivo.
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4. Plasma membrane events following KATP closure
Surprisingly, the plasma membrane of β-cells contains up to 60 channels of 16 
ion channel families [69]. Moreover, ion channels are also located on the membrane 
of IGVs to facilitate fusion with the plasma membrane and insulin exocytosis. 
Resting plasma membrane potential (Vp) is created predominantly by the activity 
of K+-channels due to a higher concentration of K+ inside the β-cell (~150 mM), 
exceeding that one established outside in capillaries or interstitial fluid (~5 mM). 
Experimentally, Vp values are measured to be approximately of – 75 mV [70]. The 
KATP closure then induces depolarization [69, 71–73] and activation of CaL [74]. 
The action potential firing is the entity that activates CaL-KV cycles (in rodents), 
however this firing is initiated by more channel types.
Surprisingly, the action potential firing is not induced until >90% of KATP channels 
are closed [75, 76]. As a result, only the closure of the remaining ~10% of the KATP 
population leads to depolarization [76]. In fact, the activity of the whole KATP popula-
tion decreases exponentially with the increasing glucose concentration. Interestingly, 
50% of the KATP population is already closed at 2–3 mM glucose, while Vp remains 
steady. However, at about 7 mM glucose, 100% of the KATP ensemble is closed. This 
is being reflected by the completely vanished KATP current, which leads to action 
potential firing [69, 70]. This event is termed as a supra-threshold depolarization.
Thus, hyperpolarized interburst phases are induced, while a nearly permanent 
firing exists at high >25 mM glucose [70]. An intermediate depolarization at 10 mM 
glucose was reported for mouse β-cells, reversed upon withdrawal of Ca2+ and Na+, 
supporting the participation of other channels, such as nonspecific cation channels, 
contributing to the depolarization (inward) flux [45]. Even an efflux of Cl− was 
suggested to fulfil this role [77], including the opening of LRRC8/VRAC anion 
channels [78, 79]. The participation of TRPM4 and TRPM5 [80] providing inward 
currents of certain levels seem to be required for induction of sufficient membrane 
depolarization together with KATP closing [46]. This is because the measured resting 
Vp of – 75 to −70 mV is already depolarized by a some extent from the equilibrium 
Vpequi of −82 mV (5 mM vs. 130 mM [K+]). The shift is probably due to the opening 
of nonspecific cation channels, since any of Na+, Ca2+ and K+ can penetrate them. 
The 100% KATP closing at higher glucose causes only an insufficient depolarization. 
Without nonspecific cation channels (or Cl− channels), the established Vp would 
only be equal to Vpequi, so any shift to −50 mV required for CaL would not take 
place. Contribution by the basal opening of other synergic channels is therefore 
essential. Open synergic channels always induce the inward shift in Vp, so to that 
depolarization given by 100% KATP closing reaches −50 mV. This allows opening 
of CaL and action potential firing. In summary, besides the heat-activated TRPV1 
channel (capsaicin receptor), and TRPV2 or TRPV4, the H2O2-activated TRPM2 [2], 
or Ca2+-activated TRPM4 and TRPM5 channels belong to the important group of 
possible synergic channels expressed in β-cells [46].
The same reasoning concerns with anion channels, particularly Cl− channels. 
The active Cl− transport is provided in β-cells by SLC12A, SLC4A, and SlC26A 
channels. These channels set the cytosolic Cl− concentration above thermodynamic 
equilibrium. Besides GABAA, GABAB and glycine receptor Cl
− channels consid-
ered to be part of the insulin secretion machinery, also volume-regulated anion 
channels (VRAC) were shown to be open at high glucose. VRACs are heteromers 
of the leucine-rich repeat containing 8 isoform A (LRRC8A) with other LLRC8 
isoforms, forming anion channels [79]. Ablation of LRRC8 in mice led to delayed 
Ca2+ responses of β-cells to glucose and diminished GSIS in mice, demonstrating 
the modulatory role of LRRC8A/VRAC on membrane depolarization leading to CaL 
responses [78, 79].
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Upon the action potential firing thus metabolically driven Vp oscillations occur 
due to the initial glucose rising [69, 70]. Cytosolic Ca2+ oscillations are superim-
posed from fast (2–60 s periods) and slow (up to several min) Ca2+ oscillations [81], 
stemming from Vp oscillations and an interplay with Ca2+ efflux from the endoplas-
mic reticulum (ER) [82]. Collectively they lead to pulsatile insulin secretion. The 
ER involvement is given by the phospholipase C (PLC), responding to the glucose-
stimulated Ca2+ influx. PLC produces inositol triphosphate (IP3), which opens the 
Ca2+ channel of IP3 receptor (IP3R) of ER; plus diacylglycerol (DAG). Importantly, 
DAG permits the opening of TRPM4 and TRPM5 via the protein kinase C (PKC) 
pathway. Another ER Ca2+ channel, the ryanodine receptor (RyR) may also partici-
pate, being activated by ATP, fructose, long-chain acyl-CoAs and cyclic adenosine 
5′-diphosphate ribose [81]. Also, the role of other channels was demonstrated for 
permitting store-operated Ca2+ entry from ER, particularly of the ternary complex 
of TRPC1/Orai1/STIM1 [46, 83]. TRPC1 belongs to the transient receptor potential 
canonical (TRPC) family with a modest Ca2+ selectivity. TRPC1 interacts with 
Orai1 [84], and in such a functional complex, its channels are activated by STIM1, 
 affecting the amplitude of Ca2+ oscillations, and correlating with GSIS.
As mentioned above, deactivation of CaL is ensured by the opening of voltage-
dependent channels (KV) in rodents [52] or calcium-dependent (KCa) K
+-channels in 
humans. Among the former, tetrameric KV2.1 is the prevalent form in rodent β-cells. A 
delayed rectifier K+-current is induced at positive Vp down to −30 mV [85]. The open-
ing of KV2.1 channels repolarizes Vp and thus closes CaL channels. Ablation of KV2.1 
thus reduces Kv currents by ~80% and prolongs the duration of the action potential, 
so more insulin is secreted. Mice with ablated KV2.1 possess lower fasting glycemia but 
elevated insulin and reportedly improved GSIS [86]. In contrast, human β-cells use 
KCa1.1 channels (i.e. BK channels) for repolarization of Vp [70]. Note also that down-
regulation of KV was observed after islet incubation with high glucose for 24 hr [87].
5. Possible redox regulations of KATP and other channels
The structure of KATP has been resolved and numerous mutagenesis studies of 
KATP have been conducted. Amino acid residues that are candidate redox targets are 
yet to be identified. The KATP channel is a hetero-octamer consisting of four external 
regulatory sulfonylurea receptor 1 (SUR1, a product of Abcc8 gene) subunits and four 
pore-forming subunits of potassium inward rectifier, Kir6.2 (Kcnj11 gene) [88, 89]. 
These Kir6.2 subunits cluster in the middle of ~18 nm size structure with a ~13 nm 
height [90]. The part exposed to the cytosol contains an ATP binding site, located 
about 2 nm below the membrane. A single ATP molecule was reported to close the 
channel, i.e. with the other three binding sites left unoccupied [91]. However, the 
ATP binding site overlaps with the binding site for phosphatidylinositol 4,5-bisphos-
phate (PIP2), which stabilizes the open state. Palmitoylation of Cys166 of Kir6.2 was 
then reported to amplify the responsiveness to PIP2 [92]. Upon the release of PIP2 
from the binding site, the open probability becomes decreased [90, 93, 94].
Diazoxide or cromakalim, as well as numerous other openers, set KATP phar-
macologically in the open state even at a high ATP concentration [95]. In contrast, 
the artificial KATP closing by sulfonylurea derivatives, such as glibenclamide, takes 
place independently of ATP. Besides this sulfonylurea binding site, each of the four 
SUR1 subunits contains MgATP and MgADP binding sites. MgATP is hydrolyzed at 
the nucleotide binding fold 1 (NBF1) to MgADP. Resulting MgADP subsequently 
activates KATP at NBF2. This is indeed reflected by the ATP-sensitive increase in K
+ 
conductance and following lower excitability, accompanied by the lower sensitivity 
to ATP inhibition [91].
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The phosphorylation of KATP reportedly sets the sensitivity of the KATP 
ensemble. The setting is such that transitions upon the glucose rise from 3 or 5 mM 
to 7 mM or > 10 mM result in the closing of the remaining 10% of the initially open 
channels by elevations between just the two ATP concentrations falling into the mM 
range. Any redox component in this was never indicated and should be studied. 
Nevertheless, phosphorylation mediated by the protein kinase A (PKA) was already 
reported to act in this unusual setting. Thus Thr224 [96] and Ser372 were reported 
to be the verified PKA phosphorylation sites. Their phosphorylation increases the 
open probability of KATP [97]. This might hypothetically provide closing mechanism 
acting at higher ATP concentration or even requiring H2O2. In a longer time scale, 
phosphorylation also increases the number of channels in the plasma membrane. 
Also, Thr224 was found to be phosphorylated by Ca2+ and calmodulin-dependent 
kinase II (CaMKII) while interacting with βIV-spectrin [98]. In vivo, also auto-
nomic innervations and paracrine stimulation ensure sufficient PKA-mediated 
 phosphorylation of KATP.
Since the original discovery of the essential role of KATP in GSIS [99], only an 
indirect inhibition of KATP by H2O2 was observed in smooth muscle cells [100]. 
Nevertheless, other redox-sensitive targets have been identified in pancreatic 
β-cells. But we can exclude the possibility that the IGV exocytosis itself might be 
directly induced by H2O2, independently of Ca
2+ [52], since the ability of exog-
enous H2O2 to induce insulin secretion in INS-1E cells was only partially blocked 
by NOX4-siRNA, but it was completely blocked by a CaL blocker nimodipine [1]. 
Consequently, albeit the used H2O2 doses exceeded 100 μM, they did not directly 
stimulate the KATP-independent exocytosis of insulin granules.
A second possibility would be that CaL channels themselves may be hypotheti-
cally co-activated by H2O2. Third, the plasma membrane depolarization might 
be redox sensitive, so that H2O2 could directly or indirectly inhibit repolarizing 
K+-channels, such as KV [101–103]. The fourth plausible redox link with GSIS 
would concern with the reported redox activation of TPRM2 depolarizing channels 
[2]. The latter is the most plausible, since it is related to a Ca2+-induced [52, 104] 
or H2O2-induced exocytosis of insulin granules by the H2O2-activation of TPRM2 
depolarizing channels [2, 105]. Note, our results excluded the Ca2+-independent 
H2O2-induced exocytosis of IGVs at least in rat pancreatic β-cells [1]. Therefore, 
if the H2O2-activated TRPM2-dependent mechanism exists, it must provide the 
required synergy with KATP, to reach the −50 mV plasma membrane depolarization 
threshold. Note also, that TRPM2 was already implicated as a significant player in 
the GLP-1 potentiation of insulin secretion [106].
Finally, a competition for NADPH between NOX4 and a hypothetical NADPH-
activated K+-channel could exist. Nevertheless, using patch-clamped INS-1E cells in 
a whole cell mode, we demonstrated a closure of KATP by H2O2 produced by NOX4 at 
high glucose, since in cells silenced for NOX4, even ATP resulting from the metabo-
lism of high glucose was unable to close the KATP channel [1].
6. Receptor-mediated amplification of insulin secretion
G protein-coupled receptors activating heterotrimeric G proteins ensure 
pleiades of cell responses, mutually interrelated. G proteins typically regulate 
production of second messengers. Thus Gαs proteins increase generation of cyclic 
AMP (cAMP), whereas Gαi/o proteins decrease it [107–109]. The G proteins Gαq/11 
initiate PLC-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate into 
diacylglycerol (DAG) and IP3 [110, 111]. Gα12/13 proteins promote protein RhoA 
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for remodeling of the cytoskeleton [112]. Class of proteins termed β-arrestins initi-
ates signaling via proximal MAP kinase, IκB, and Akt pathways [113]. The latter two 
G protein classes rather control long-term effects.
Let us emphasize downstream pathways that are important for acute effects in 
pancreatic β-cells, which predominantly lead to either modulation of the plasma 
membrane channels, typically CaL, KATP and KV, so to ensure more intensive insulin 
secretion; or their action evokes stimulation of insulin secretion via ensuring the 
surplus Ca2+ influx to the cytosol from ER or mitochondria; or, else, their action 
targets proteins of the exocytotic machinery on the IGV or plasma membranes. The 
latter responses alter the kinetics of IGVs in docking, priming and fusion with the 
plasma membrane, so to facilitate exocytosis. Interestingly, these events could be 
independent of CaL and theoretically could take place at low glucose concentrations.
Activation of Gαs increases the activity of transmembrane adenylate cyclases 
(tmAC) producing cAMP from ATP [108, 109]. A number of phosphodiester-
ases (of 11 families) degrade cAMP (some also or exclusively cGMP). cAMP is 
a universal 2nd messenger having a specific function in amplifying of GSIS and 
insulin secretion stimulated with other secretagogues. Also, soluble adenylate 
cyclases (sACs) exist, notably in the mitochondrial matrix, while their reaction 
is potentiated by Ca2+ and bicarbonate. The major mediators of cAMP effects are 
cAMP-dependent PKA [114], including PKA tethered to the outer mitochondrial 
membrane [115, 116], and the parallel pathway of enhanced signaling via exchange 
proteins directly activated by cAMP 2 (EPAC2) [117–119].
In pancreatic β-cells, the PKA pathway is involved in signaling of incretin 
(GLP-1 and GIP) receptors [107, 120]. It exerts a minor contribution to signaling 
from metabotropic receptors, such as GPR40, which is sensing long chain fatty 
acids [111]. PKA typically amplifies the Ca2+-dependent exocytosis of insulin 
granules. The core pathway involves PKA phosphorylation and hence activation 
of the CaL β2-subunit, in concert with KATP phosphorylation decreasing the ATP 
concentration range required for its closure (see above) [121]. In addition, PKA 
inhibits Kv channels, which otherwise terminate plasma membrane depolarization; 
hence this prolongs already more intensive Ca2+ influx via phosphorylated CaL and 
hence exocytosis of insulin granules [122].
Another PKA target is the exocytosis-modulating protein termed snapin, 
the phosphorylation of which allows its interaction with the other IGV proteins, 
which enhances the 1st GSIS phase [123]. Snapin participates in tethering of IGVs 
to the plasma membrane by coiled-coil interaction with a lipid-anchored protein 
SNAP-25 [124].
Altogether, the PKA pathway ensures about 50% of cAMP responses in β-cells 
[125], while the EPAC2 pathway ensures the remaining responses [117–119]. EPAC2 
protein possesses a guanine nucleotide exchange activity, thus inducing the Ca2+-
induced Ca2+release from ER via RyR [126] (questioned in [127]), occurring only 
at high glucose, since it requires the primary CaL opening [128], which also par-
tially refills the ER Ca2+ stores. The EPAC2 pathway also affects the IGV proteins 
and thus facilitates the insulin exocytosis. For example, Rim2a protein is a target 
[129, 130], located on the inner plasma membrane surface and on IGVs, represent-
ing a scaffold for IGV exocytosis [131]. Rim2a interacts with Rab3A of IGVs and 
the resulting Rim2a-Rab3A complex facilitates docking of IGVs into the plasma 
membrane. This is followed by so-called priming, which is subsequently initiated 
by the Rim2a interaction with the Munc13–1 protein. Munc13–1 then opens syn-
taxin 1 from its closed conformation, thus allowing fusion with the plasma mem-
brane. EPAC2 also interacts with NBD1 of SUR1, being released by cAMP [35]. 
Such locally released EPAC2 induces the release of Rim2 from the α1.2 CaL subunit. 
Type 2 Diabetes - From Pathophysiology to Cyber Systems
10
The local Ca2+ influx within CaL ensures EPAC2 binding to Rim2, and subsequent 
interaction with another Ca2+ sensor termed Piccolo. The heterotrimeric complex 
then interacts with Rab3A and enables IGV exocytosis.
Interestingly, all necessary components of the PKA pathway were identified 
in the mitochondrial matrix, including sAC, PDE2A2 [132], and also PKA [133]. 
However, we may also speculate that some proteins can be phosphorylated by 
cytosolic PKA or by its fraction attached to OMM prior to their import to the mito-
chondrial matrix. There was also a consensus that cAMP cannot freely diffuse to the 
matrix [132]. Thus cAMP in the mitochondrial matrix may act as an independent 
pool [134, 135]. Its source is the matrix-located soluble adenylate cyclase sAC, which 
is activated by bicarbonate and Ca2+ [136, 137]. Since CO2 is increasingly released 
when the Krebs cycle turnover increases upon GSIS, the matrix localized mtPKA 
can be activated in this way [138]. In any case, OXPHOS is facilitated in mito-
chondria of numerous tissues via phosphorylation of Complex I NDUFS4 subunit 
(facilitating its Hsp70-mediated import), Complex IV COXIV-1 subunit (prevent-
ing its inhibition by ATP) [139] as well as via IF1, enhancing ATP synthesis by 
disabling the inhibitory binding of phosphorylated IF1 dimers to the ATP synthase 
[140]. A link to redox homeostasis can be viewed in the observed release of the PKA 
catalytic subunits by the increased ROS [141, 142]. Thus mtPKA can act in parallel 
to the cytosolic PKA signaling initiated by GPR40 and GLPR or GIPR receptors. 
PKA targeting of at least IF1, and probably also of Complex I and Complex IV, 
should contribute to the amplification of insulin secretion by FAs or incretins.
The G protein Gαq/11 initiates signaling through the phospholipase C (PLC-)-
mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate into DAG and inositol 
triphosphate IP3 [110]. The main effector of DAG is protein kinase C (PKC), which 
is activated by DAG. One of the effectors of IP3 is the IP3 receptor (IP3R; subtypes 
IP3R1, IP3R2 and IP3R3), which is another important Ca2+ channel residing on ER 
membranes in β-cells [143]. Similarly to the EPAC2-RyR route of Ca2+ release from 
ER Ca2+, the opening of this channel amplifies the primary CaL mediated Ca
2+ 
signaling for insulin release. PKC contributes to the plasma membrane depolariza-
tion, while activating TRPM4 and TRPM5 [144]. Besides the canonical plasma 
membrane effects, PKC and downstream ERK1/2 signaling stimulates OXPHOS, 
hence mitochondrial ATP synthesis [145].
7. GSIS amplification by incretins GLP-1 and GIP
Glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) have a 
prominent impact among other peptides belonging to incretins [107–109]. Oral glu-
cose administration provides a higher insulin secretion response than when admin-
istered parenterally [146]. This surplus of potentiation of insulin secretion appears 
to be about equally ascribed to GLP-1 and GIP [147]. Indeed, diminished insulin 
secretion response to oral glucose was observed in GLP-1 knock out mice [148, 149] 
and was even more decreased in double knockout mice (GLP-1 plus GIP) [149].
Incretin-cAMP signaling amplifies GSIS by both PKA-dependent and EPAC2A-
dependent pathways. As described above, the EPAC2 pathway is partially dependent 
on the CaL opening, and the PKA pathway enables synergy among actions of KATP, 
CaL, and Kv channels, leading again to a more effective CaL opening. This knowl-
edge complies with the traditional view, considering that the incretin signaling does 
not stimulate insulin release in the low glucose conditions [150, 151]. The GLP1R-
cAMP-EPAC2-TRPM2 pathway was suggested to be one of the major routes [106].
GLP-1 is secreted by enteroendocrine L-cells, residing predominantly in the 
distal ileum and colon. Secretion is initiated by postprandial stimuli, i.e. by glucose, 
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fatty acids, or lipids, as well as proteins [152, 153]. Only 10 to 15% of active GLP-1 
likely reaches the pancreas via the circulation [154]. Thus concentrations of bio-
logically active GLP-1 in human plasma at fasting account for about 2 pmol/l and 
maximum10 pmol/l postprandially [155], peaking 30 to 60 min after a carbohydrate 
or protein intake and 120 min after ingestion of lipids [156]. The most efficient 
truncated variants are GLP-1(7–37) and variant GLP-1(7–36amide) [152]. The latter is 
~80% abundant in humans [157]. Note that full peptide GLP-1(1–37) is much less 
efficient in GSIS potentiation [150, 151]. Moreover, paracrine GLP-1 signaling acts 
among the different types of PI cells [150], similarly to the paracrine and endocrine 
secretion of other hormones. On the systemic level, central control by the brain 
and nervous system, including GLP-1 secretion in the nucleus tractus solitarii of 
the brainstem [152], further provides an indispensable top level of regulation for 
the insulin secretion. GLP-1 effects related to β-cell proliferation or apoptosis are 
beyond the scope of this review.
GLP-1 from the bloodstream acts through its receptor (GLP1R) residing in the 
plasma membrane of pancreatic β-cells [158]. GLP1R activation stimulates Gαs and 
Gαq/11 and recruits β-arrestin, depending on biased agonism relative to different 
agonists, such as exendin-4 and oxyntomodulin [159, 160]. As a scaffold protein, 
β-arrestin facilitates signaling via Gαs to cAMP but also to CREB [160], extracellular 
regulated kinase ERK1/2 [161], and insulin receptor substrate 2 (IRS-2), the effects 
promoting β-cell growth, differentiation, and maintenance [160]. The stimula-
tion of Gαs leads via enhanced cAMP to the initiation of PKA [162] and EPAC2A 
pathways [163]. Continuous cAMP production and partial potentiation of GSIS was 
found even for the internalized GLP1R [164].
The PKA pathway provides a surplus intracellular Ca2+ above that of the net 
GSIS without any receptor stimulation. This is ensured by phosphorylation-induced 
closing among the population of KATP, stimulation of CaL opening, and closing 
of Kv channels [165]. The latter prolongs Ca2+ stimulation of IGV exocytosis and 
hence may also potentiate the 2nd phase of GSIS. In parallel, PKA engages snapin 
interaction with IGVs, reportedly potentiating the 1st GSIS phase [123, 124]. 
Simultaneously, the EPAC2 pathway promotes Ca2+-induced RyR-mediated Ca2+ 
release from ER, which must be, however, initiated by the ongoing CaL opening 
[163]. The EPAC2 pathway also facilitates docking and priming of IGVs by promot-
ing Rab3A interaction with Rim2a [131] and hypothetically interaction of EPAC2-
Rim2-Picollo trimers with Rab3A, enabling IGV exocytosis [152]. Stimulation of 
GLP1R biased downstream via stimulation of Gαq/11 also contributes by a surplus 
to intracellular Ca2+, while inducing the IP3R-mediated Ca2+ release from ER.
When GLP1 effects were simulated and IGV kinetics was monitored using 
total internal reflection fluorescence microscopy, cAMP and 8-Br-cAMP were 
found to increase the frequency of fusion events, i.e. IGV fusion with the plasma 
membrane in both phases of GSIS [25]. EPAC2A was found to interacts also with a 
small G protein Rap1, affecting its conformation so to release the catalytic region, 
which subsequently binds and thus activates another G protein Rap113. In EPAC2A 
knockout mice, most of the potentiation of the 1st GSIS phase vanished [25]. Thus 
speculatively, the 2nd phase amplification can be due to the PKA pathway.
8.  Mechanism of insulin secretion stimulated by branched-chain 
keto-acids
Postprandial response by insulin secretion is also given by substances other 
than glucose. These substances, which induce the secretion of insulin, are termed 
secretagogues in general. One important type of secretagogues is branched-chain 
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keto-acids (BCKAs), metabolites of branched-chain amino acids (BCAAs) 
(Figure 2). We found that the alternative to the NOX4-mediated redox signaling 
exists for some other insulin secretagogues, particularly for BCKAs [1]. For the 
redox signaling in this case, the mitochondrial redox signaling replaced that one 
originating from NOX4. Thus we demonstrated that H2O2 signaling originating 
from mitochondria is essentially required for insulin secretion stimulated by BCAAs 
metabolized onto BCKAs, such as 2-ketoisocaproate (KIC; also termed 2-oxoiso-
caproate, OIC; leucine metabolite), 2-ketoisovalerate (KIV; valine metabolite) and 
2-ketomethylvalerate (KMV; isoleucine metabolite) [166, 167]. This mechanism 
was evidenced by the effects of mitochondrial-matrix-targeted antioxidant SkQ1. 
We observed that SkQ1 did not affect GSIS in INS-1E cells, but completely inhibited 
insulin secretion stimulated by KIC [1]. Thus the NOX4 source of H2O2 cannot be 
efficiently inhibited by SkQ1 located within the inner phospholipid leaflet of the 
inner mitochondrial membrane, whereas the redox signaling originating from 
mitochondrion must be blocked.
Metabolism of BCKAs begins in the mitochondrial matrix by the reaction of the 
BCKA dehydrogenase complex (BCKDH), since there is no branched-chain amino 
acid aminotransferase (BCAT) in the cell cytosol [168]. BCKDH forms isovaleryl-
CoA, isobutyryl-Co and methyl-isobutyryl-CoA from KIC, KIV and KMV, 
respectively. This is followed by a series of reactions resembling β-oxidation of fatty 
acids. This series, as well as FA β-oxidation, elevates formation of superoxide in 
the mitochondrial matrix by several ways. The major way is due to the reoxidation 
of the BCKDH co-factor FADH2 by the electron-transfer flavoprotein (ETF), the 
one electron carrier. Two electrons from the two ETF molecules are accepted by 
the electron-transfer flavoprotein: ubiquinone oxidoreductase (ETF:QOR) [169]. 
Figure 2. 
The mechanism of branched chain keto acid-stimulated insulin secretion involves redox signaling of 
mitochondrial origin. 2-ketoisocaproate (KIC), 2-ketomethylvalerate (KMV) and 2-ketoisovalerate (KIV) 
resulting from leucine, isoleucine, and valine, respectively, due to the branched chain aminotransferase reaction 
in mitochondria (BCAT2), are metabolized by the branched chain ketoacid dehydrogenase (BCKDH) in 
mitochondria. A series of reactions, BCKA oxidation leads to the electron transfer from the co-factor FADH2 
of BCKDH, via ETF towards the ETF:QOR reaction reducing Q to QH2. This effectively retards the competing 
reaction of the Complex I of the mitochondrial respiratory chain, leading to the superoxide formation. In 
the mitochondrial matrix, superoxide is transformed to H2O2 by MnSOD, whereas by CuZnSOD in the 
intermembrane space and cytosol. The elevated mitochondrial/cytosolic H2O2 substitutes the redox signal 
of NOX4 origin. Consequently, such redox signaling, together with elevated ATP, allows the sufficient 
depolarization of the plasma membrane.
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ETF:QOR reaction is coupled to ubiquinone (Q ) oxidation to ubiquinol (QH2). 
This effectively competes with the Complex I reaction of the respiratory chain, also 
providing Q oxidation to QH2 driven by NADH. The electron transfer within the 
Complex I is thus effectively retarded and this results in a higher superoxide forma-
tion. Superoxide is then most probably increasingly formed at the IQ site (i.e. at the 
proximity of the Q-binding site), similarly as due to the reverse electron transfer.
Alternatively, the Complex I electron transfer is retarded upon the acetyl-CoA 
entry (propionyl-CoA entry for KIV; through methylmalonyl and Succinyl-CoA) 
into the Krebs cycle. Also, acetoacetate influences redox homeostasis, as one of the 
final products of leucine metabolism. After superoxide conversion to the elevated 
H2O2 in the mitochondrial matrix, the H2O2 is elevated in the cytosol and thus 
represents the mitochondrial retrograde redox signaling. Its target could be again 
KATP (or KATP and TRPM2) which would depolarize the plasma membrane due to 
this redox signaling ongoing in parallel with the elevated ATP due to concomitantly 
enhanced OXPHOS.
The BCAA oxidation involves the following sequence of reactions: isovaleryl-
CoA dehydrogenase (IVD), methylcrotonyl-CoA carboxylase (MCC), methyl-
glutoconyl-CoA hydratase (MGCoAH) and 3-hydroxy-3-methylglutaryl-CoA lyase 
(HMGCoAL). The end-products are acetyl-CoA and acetoacetate. Similarly, as for 
pyruvate metabolism via PDH, the common end-product acetyl-CoA drives the 
Krebs cycle. This may also increase mitochondrial superoxide formation. Acetyl-
CoA is linked to the above acyl-CoA dehydrogenase reaction by the reaction of the 
ETF:QOR, using ubiquinone (CoQ or Q ) to oxidize it to ubiquinol QH. Also, the 
ETF:QOR itself may produce superoxide.
In summary, independently of the molecular mechanism, BCAA metabolism 
leads to the increased mitochondrial superoxide formation. After conversion to 
H2O2 by the matrix MnSOD and the intermembrane space CuZnSOD, the ongoing 
H2O2 efflux from mitochondria can be regarded as redox signaling. We have clearly 
demonstrated that the absence of such redox signaling, for example, in the presence 
of the mitochondrial matrix-targeted antioxidants SkQ1 leads to a blockage of insu-
lin secretion, which is otherwise stimulated with BCKAs [1]. Likewise, the silencing 
of BCKDH led to the inhibition of insulin secretion stimulated with BCKAs.
9. Mechanism of fatty acid-stimulated insulin secretion
Fatty acids (FAs) appear in pancreatic islet capillaries either bound to albumin 
or being part of postprandial chylomicrons resulting from dietary fat lipids. FA pool 
of lipoproteins can be also considered. The dietary fat lipids are rich in triglycerides, 
which are cleaved locally in pancreatic islet capillaries by lipoprotein lipase secreted 
by β-cells. Resulting 2-monoacylglycerol (2MAG) and long chain FAs [170–173] 
stimulate each own two receptors GPR119 [157] and GPR40/FFA1, respectively. 
Therefore, fatty acid-stimulated insulin secretion (FASIS) could be defined as the 
net insulin secretion induced at the low glucose concentration, which itself does not 
stimulate insulin secretion. It is still controversial, whether such a net FASIS exists, 
since some previous reports observed that glucose should always be present for fatty 
acid to induce insulin secretion response. In contrast, the other reports described 
FASIS at 3 mM glucose, but not at zero glucose. Physiologically, postprandial 
responses should be due to all secretagogues resulting from major saccharide, fat 
and protein components. FASIS may dominate late responses upon feeding by fatty 
meal or an experimental high-fat diet [174].
Theoretically, FASIS must concern with the two components (Figure 3). The first 
one should depend on metabolism and the second one should rely on the stimulation 
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of the metabotropic receptor GPR40. In vivo, FASIS-GPR40 axis is paralleled by a 
portion of insulin secretion stimulated via another metabotropic receptor, GPR119, 
to which monoacylglycerol (MAG) binds as the second major component of tri-
glycerides. The metabolic component undoubtedly involves fatty acid β-oxidation, 
providing both ATP from the elevated OXPHOS and H2O2 from the enhanced 
superoxide formation by the respiratory chain and ETF:QOR, similarly as for BCKAs 
[175]. This component is thus directly dependent on KATP, since it leads to its closure 
and to the canonical downstream events identical to those during GSIS.
Figure 3. 
(A) Traditional (“standard”) view of FASIS compared with (B) FASIS with GPR40 receptor supplied by the 
mitochondrial fatty acids mechanism (“novel view”). The mechanism of FASIS at low glucose appears to be 
predominantly mediated by GPR40. Its ligands are free long-chain FAs. An excessive supply of GPR40 ligands 
and hence a substantial amplification of the GPR40 downstream response is given by the redox-activated 
mitochondrial phospholipase iPLA2γ/PNPLA8. The phospholipase iPLA2γ is directly activated by the elevated 
H2O2 in the mitochondrial matrix and cleaves both saturated and unsaturated FAs from the phospholipids 
of mitochondrial membranes. The cleaved free FAs diffuse up to the plasma membrane, where they activate 
GPR40.
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The receptor component of FASIS may be at least partly KATP-independent and 
even CaL-independent, hence may partly proceed independently of high glucose. 
In other words, FASIS at low glucose is theoretically possible. The major pathway 
downstream of GPR40 relies on Gαq/11, which induces PLC-mediated hydrolysis of 
phosphatidylinositol 4,5-bisphosphate into DAG and IP3 [110, 111]. The latter would 
amplify the primary CaL-mediated Ca
2+ signaling for the insulin release by mediat-
ing Ca2+ release from ER via the Ca2+ channel of the IP3 receptor [143]. However, 
this would happen provided that some basal CaL would be initiated by the metabolic 
component, i.e. due to partial fatty acid metabolism by β-oxidation followed by H2O2 
plus ATP elevations. Also, PKC could be activated downstream of GPR40 as being 
the main effector of DAG. The PKC pathway could increase the extent of plasma 
membrane depolarization since it activates TRPM4 and TRPM5 [144]. Moreover, 
this may act at low glucose, again providing that the initial triggering is ensured by 
the metabolic component, and so that certain basal H2O2 plus ATP elevations exist, 
leading to the KATP closure. Also, another route downstream of GPR40 would involve 
the Gαq/11-PLC-TRPC-induced Ca2+ efflux from ER [176]. As mentioned above, the 
TRPC1-Orai1-STIM1 complex was demonstrated to act during GSIS, while con-
tributing to Ca2+ oscillations [46, 83, 84]. The action of such a complex has yet to be 
studied during experimental FASIS as well as its dependence on CaL.
Also, biased (promiscuous) pathways of GPR40, i.e., those involving GαS-cAMP 
initiation of information signaling may exist and contribute to a certain extent to 
FASIS. Both downstream pathways of GPR40-GαS-cAMP stimulation, i.e. the PKA 
and EPAC2 pathway, could target components of IGV interactions with the plasma 
membrane, hence being independent of CaL. These speculations await experimental 
evidence.
Our in vitro and in vivo experiments with mice (unpublished) demonstrated 
that approximately 2/3 of the GPR40 response (amplitude of insulin secretion) 
is given by the amplifying mechanism due to the mitochondrial phospholipase 
iPLA2γ/PNPLA8 [175]. This phospholipase cleaves both saturated and unsatu-
rated FAs from the phospholipids of mitochondrial membranes. The cleaved 
free FAs subsequently diffuse up to the plasma membrane, where they activate 
GPR40. Moreover, the phospholipase iPLA2γ is directly activated by the elevated 
H2O2 in the mitochondrial matrix. The reader may remain that this is just the FA 
β-oxidation, which via the increased superoxide formation, due to the function of 
ETF:QOR and respiratory chain, produces H2O2, while the concomitant OXPHOS 
provides elevated ATP. As a result, the sufficient plasma membrane depolariza-
tion is enabled. The proof of co-existence of the GPR40 receptor component and 
metabolic component of FASIS is suggested by the experiments when FASIS in 
iPLA2γ knockout mice or in its isolated islets yielded only ~30% insulin secretion 
peak in the 1st phase when compared to wt mice (Holendová B., Jabůrek M, et al., 
unpublished). Incidentally, a similar portion remains when GW1100 antagonist of 
GPR40 was applied. These results show that in parallel with the GPR40 pathway, a 
1/3 portion of FASIS still results from FA β-oxidation, having a similar mechanism 
as described for ketoacids. The abolished FASIS in the iPLA2γ knockout mice then 
supports the existence of such an acute mechanism in vivo, when GPR40 is supplied 
with mitochondrial fatty acids.
10. Redox relay as a hypothetical carrier for redox signaling
It has been established that the content of glutathione (GSH) is rather low 
in pancreatic β-cells [177–180], in contrast to the content of thioredoxins and 
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glutaredoxins [181, 182], peroxiredoxins and other proteins capable of redox 
relay. Therefore, these proteins are able to conduct and spread the redox signals 
[183, 184]. From this point of view, the pancreatic β-cell appears to be a well-
integrated redox system.
Redox signal spreading may be accomplished either by the direct diffusion of 
H2O2 or may be facilitated by the specialized proteins. Redox signals can be traced 
experimentally as instantly oxidatively modified cysteine residues, which are 
spread via different sets of proteins in different tissues. However, one may consider 
their majority as passive targets. For the case of NOX4 residing in the proximity of 
KATP, undoubtedly, the direct diffusion of H2O2 would be sufficient. Nevertheless 
for more distant NOX4 molecules, this would be difficult. Also, for mitochondrial 
redox signaling towards targets residing in the plasma membrane, a distance 
over 500 nm must be overcome. Redox signal across such high distances could be 
conducted through the action of thiol-based proteins capable of redox relay to the 
target, such as peroxiredoxins (regenerated via thioredoxins and glutaredoxins). 
The relay would provide a common redox signal transfer. It is yet to be established 
whether a redox relay exists via an array of peroxiredoxin oligomers.
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